Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
01/2007
01/18/2007DE112005000477T5 Mikroarraysubstrat für Biopolymere, Hybridisierungseinrichtungen und Hybridisierungsverfahren Microarray substrate for biopolymers, hybridization facilities and hybridization methods
01/18/2007DE10247896B4 Mehrdimensionale Trennung von Biosubstanzgemischen für massenspektrometrische Analysen Multidimensional separation of Biosubstanzgemischen for mass spectrometric analyzes
01/18/2007DE102006012317A1 New macromolecular compounds comprising nucleotide and nucleoside building blocks, are useful in enzymatic reactions and nucleic acid analysis
01/18/2007DE102006003777A1 Vorrichtung zur Verarbeitung biologischer Proben Apparatus for processing biological samples
01/18/2007DE102005034129A1 Immunological method for determining biomolecules, useful e.g. in medicine and environmental analysis, uses a tetraamino-biimidazole as label, functioning both as dye precursor and source of hydrogen peroxide
01/18/2007DE102005010552B4 Vorrichtung und Verfahren zur Detektion von Fehlern auf bewegten Gegenständen Device and method for the detection of errors on moving objects
01/18/2007CA2652767A1 Method for evaluating cell populations
01/18/2007CA2652232A1 Novel carbohydrate profile compositions from human cells and methods for analysis and modification thereof
01/18/2007CA2615078A1 Methods for determining the effect of a treatment on the cross-.beta. structure content of a protein; selection of treatments and uses thereof
01/18/2007CA2615028A1 Cross-.beta. structure binding compounds
01/18/2007CA2615025A1 A method for detecting peptides comprising a cross-.beta. structure
01/18/2007CA2614961A1 Methods for predicting urine ph
01/18/2007CA2614952A1 Method of treating human volume expansion mediated hypertension employing resibufogenin
01/18/2007CA2614941A1 Method for detecting peptides comprising a cross-beta structure
01/18/2007CA2614893A1 Stable quantitation and detection of immune response levels with non-zero background peptides
01/18/2007CA2614737A1 Methods for monitoring neuroinflammatory destruction of neurons and for treating diseases having an inflammatory component related to phospholipase a2
01/18/2007CA2614680A1 Il-32 modulators
01/18/2007CA2614556A1 Photonic crystal biosensor fabrication method
01/18/2007CA2614392A1 Treatment of cancer patients exhibiting activation of the p-glycoprotein efflux pump mechanism
01/18/2007CA2614289A1 Methods for identifying agents and conditions that modulate neurogenesis
01/18/2007CA2614183A1 Anti-alpha v beta 6 antibodies and uses thereof
01/18/2007CA2613991A1 Diagnostic method for brain damage-related disorders
01/18/2007CA2612753A1 Immobilisation of biological molecules
01/18/2007CA2611297A1 Use of ionic matrices for maldi mass spectrometry analysis of tissue sections
01/18/2007CA2609597A1 Method for evaluating the effects of smoke on bronchioles
01/18/2007CA2552168A1 Artificial vision inspection method and system
01/17/2007EP1744162A1 Cancer diagnosis and treatment using anti-robo1 antibody
01/17/2007EP1744161A1 Substrate for detecting analyte
01/17/2007EP1744160A2 Method of invasiveness control and use of adiponectin
01/17/2007EP1744159A1 Method of assaying apolipoprotein b-48 and use thereof
01/17/2007EP1744158A1 Method for determining the metabolic stability of sludge
01/17/2007EP1744049A2 Vehicle mounted type fuel testing apparatus
01/17/2007EP1743947A2 Method for diagnosing non-small cell lung cancers
01/17/2007EP1743944A1 Novel method of screening
01/17/2007EP1743941A1 Novel mite allergen
01/17/2007EP1743940A1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide
01/17/2007EP1743653A1 Composition for increasing body height
01/17/2007EP1743649A1 Treatment and diagnosis of infertility using TGF beta or activin
01/17/2007EP1743523A1 Nonhuman transgenic animal as type 2 diabetes model
01/17/2007EP1743521A1 Method of constructing animal model suffering from left ventricular diastolic disorder for examining heart failure and method of examining remedy for heart failure caused by left ventricular diastolic failure with the use of the animal model
01/17/2007EP1743179A2 Method for the diagnosis of chronic stress and related disorders
01/17/2007EP1743178A2 Method for identifying a ligand capable of selectively modulating a functional cascade involving a target, and uses thereof for high-throughput screening of molecules of interest
01/17/2007EP1743177A2 Method for characterising compounds
01/17/2007EP1743176A1 Method for the detection of a neurological or psychiatric, demential disease, especially alzheimer's disease by use of cholecystokinin (cck)-molecules, corresponding substances and detection reagents
01/17/2007EP1743175A1 Cultispot assay
01/17/2007EP1743174A2 Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof
01/17/2007EP1743173A1 Analysis array comprising heatable electrodes, and methods for chemical and biochemical analysis
01/17/2007EP1743172A2 Detection and quantification of intracellular pathogens
01/17/2007EP1743171A2 Mechanical device for mixing a fluid sample with a treatment solution
01/17/2007EP1743169A1 Device for sensing of motile living organisms and uses thereof
01/17/2007EP1743168A2 Identification and characterization of proteins using new database search modes
01/17/2007EP1743167A1 Method for on-line monitoring of condition of non-aqueous fluids
01/17/2007EP1743166A2 Methods and systems for detection of macrolides
01/17/2007EP1743165A1 Devices, systems and methods for testing gas sensors and correcting gas sensor output
01/17/2007EP1743164A2 Fast perfusion system and patch clamp technique utilizing an interface chamber system having high throughput and low volume requirements
01/17/2007EP1743163A1 Method and device for determining the boiling point of a liquid medium
01/17/2007EP1743145A2 Method for compensation of near-neighbor sample effects in a nmr check weighing system
01/17/2007EP1743043A2 High throughput discovery of materials through vapor phase synthesis
01/17/2007EP1743040A2 Hdm2-inhibitor complexes and uses thereof
01/17/2007EP1743038A2 Mn/ca ix/ ca9 and renal cancer prognosis
01/17/2007EP1743037A1 Method for the isolation of specific molecules which bind in a highly selective manner to selected target molecules
01/17/2007EP1743033A1 Gm3 synthase as a therapeutic target in microvascular complications of diabetes
01/17/2007EP1743032A2 Methods and apparatus for detection of viral infection
01/17/2007EP1743031A2 Platelet biomarkers for the detection of disease
01/17/2007EP1743022A2 Methods and compositions for hair growth
01/17/2007EP1742969A2 Methods of identifying neoplasm-specific antibodies and uses thereof
01/17/2007EP1742965A2 Treatments for pancreatic cancer
01/17/2007EP1742964A2 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation
01/17/2007EP1742741A2 Clot retainer
01/17/2007EP1742740A1 Porous substrate plates and the use thereof
01/17/2007EP1742658A2 Cellular permissivity factor for viruses, and uses thereof
01/17/2007EP1742654A2 Anti-lfl2 antibodies for the diagnosis, prognosis and treatment of cancer
01/17/2007EP1742650A1 Improvements in cancer treatment and cancer treatment efficacy prediction by blocking and detecting protease inhibitors
01/17/2007EP1742611A2 Remote control release of material encapsulated in polyelectrolyte multilayer microcapsules
01/17/2007EP1726960A9 Means and methods for the detection of anti-Borrelia-antibodies and kit for the use in the diagnosis of Lyme-Borrelia infections
01/17/2007EP1719524A9 Nuclear transfer promoter for rac protein and method of screening the same
01/17/2007EP1595132B1 Method for analysis of contaminants in a process fluid stream
01/17/2007EP1592964B1 Microwave resonator and textile machine comprising such a resonator
01/17/2007EP1579215A4 Methods of biosensing using fluorescent polymers and quencher-tether-ligand bioconjugates
01/17/2007EP1546717A4 Analyzing nerve cell damage
01/17/2007EP1546369A4 Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway
01/17/2007EP1540010A4 Use of biomarkers for detecting ovarian cancer
01/17/2007EP1538445B1 Immunochromatography system and method for the simultaneous identification of aga and t-tg antibodies and use thereof for the diagnosis of celiac disease
01/17/2007EP1503660B1 Real time self-adjusting calibration algorithm
01/17/2007EP1490668A4 Method and apparatus for storing and dispensing reagents
01/17/2007EP1368657B1 A kit and method for detecting fecal parasites
01/17/2007EP1340088B1 In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
01/17/2007EP1335646B1 Transgenic or recombinant non-human mammals for stop protein and their uses in screening psycho-active medicines
01/17/2007EP1307134A4 Diagnostic device for distinguishing between normal and ectopic pregnancy and method for preparing the same
01/17/2007EP1301630B1 Diagnostic method for the identification of foetal dna in a maternal sample
01/17/2007EP1301539B1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
01/17/2007EP1297174B1 Interaction of tbx2 and the arf promoter in cell cycle regulator assays
01/17/2007EP1281067B1 Method for high-throughput lead profiling
01/17/2007EP1274745B1 Magnetic, silanised polyvinylalcohol-basedcarrier materials
01/17/2007EP1226417B1 Method and device for in situ triaxial test
01/17/2007EP1203226B1 Gas sensor
01/17/2007EP1140174B1 Antagonist antibodies of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines
01/17/2007EP1131430B1 Mitogenic regulators
01/17/2007EP1078072B1 New peptide fragments for protein purification
01/17/2007EP1076704B1 Il-2 selective agonists and antagonists